`

TG Therapeutics, Inc

Biotechnology Research

Specialities :
Biotechnology
Hematological malignancies
Non-hodgkin's lymphoma
Multiple sclerosis
B-cell diseases

+2

Sign Up to View More
revenue-icon Revenue
101M - 500M
funding-icon Total Funding
$70.0M
size-icon Size
201 - 500
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About TG Therapeutics, Inc

What does Tg therapeutics, inc do?+

TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS)

What are Tg therapeutics, inc's specialties? +

Biotechnology,hematological malignancies,non-hodgkin's lymphoma,multiple sclerosis,b-cell diseases,ublituximab,and umbralisib

What is Tg therapeutics, inc's industry? +

Tg therapeutics, inc operates in the Biotechnology research industry.

What is Tg therapeutics, inc's revenue? +

Tg therapeutics, inc's revenue is 101m - 500m

What is Tg therapeutics, inc's company size? +

Tg therapeutics, inc has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free